GlobeNewswire Inc | Sep 22, 2021 04:05PM EDT

September 22, 2021

CAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.(Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today thatPaul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Chardan Virtual Genetic Medicines Conference onMonday, October 4, 2021at2:00 p.m. ET.

A live webcast of the presentation will be available on the Investor Relations page of theWave Life Sciencescorporate website at http://ir.wavelifesciences.com.A replay of the presentation will be archived and available at that site for a limited time following the event.

AboutWave Life SciencesWave Life Sciences(Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the companys proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visitwww.wavelifesciences.comand follow Wave on Twitter @WaveLifeSci.

Investor Contact:Kate Rausch617-949-4827krausch@wavelifesci.com

Media Contact:Alicia Suter617-949-4817asuter@wavelifesci.com